SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-122206
Filing Date
2024-04-29
Accepted
2024-04-29 16:04:02
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-29

Document Format Files

Seq Description Document Type Size
1 ARS d748670dars.pdf ARS 7652396
  Complete submission text file 0001193125-24-122206.txt   10541778
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36510 | Film No.: 24890547
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)